M ATASSI to Antibody Formation
This is a "connection" page, showing publications M ATASSI has written about Antibody Formation.
Connection Strength
2.008
-
Antibody responses to botulinum neurotoxin type A of toxin-treated spastic equinus children with cerebral palsy: A randomized clinical trial comparing two injection schedules. J Neuroimmunol. 2017 05 15; 306:31-39.
Score: 0.502
-
Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin. Sci Rep. 2015 Oct 28; 5:15776.
Score: 0.458
-
Reduction of established antibody responses against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol peptide conjugates. J Neuroimmunol. 2014 Jul 15; 272(1-2):29-34.
Score: 0.103
-
Reduction of antibody response against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol-peptide conjugates. Immunol Lett. 2011 Jun 30; 137(1-2):46-52.
Score: 0.083
-
Antibody response to transfusion with pyridoxalated polymerized hemoglobin solution. Mil Med. 1987 Sep; 152(9):473-7.
Score: 0.065
-
Use of alum and inactive Bordetella pertussis for generation of antibodies against synthetic peptides in mice. Immunol Invest. 2006; 35(2):137-48.
Score: 0.058
-
Vaccination with a MHC class II peptide in Alum and inactive pertussis strongly ameliorates clinical MG in C57BL/6 mice. J Neuroimmunol. 2006 Feb; 171(1-2):8-16.
Score: 0.057
-
T-cell dependency of the antibody response to free small synthetic peptides of a protein: demonstration with an antigenic site of myoglobin. Immunol Invest. 1985 Feb; 14(1):1-5.
Score: 0.054
-
Discovery and implications of the immunogenicity of free small synthetic peptides: powerful tools for manipulating the immune system and for production of antibodies and T cells of preselected submolecular specificities. Crit Rev Immunol. 1985; 5(4):387-409.
Score: 0.054
-
Genetic control of the immune response to myoglobin. XVI. Control of antibodies with preselected specificities following immunization with free synthetic peptides representing the antigenic sites or surface non-immunogenic locations in the protein. J Immunogenet. 1983 Dec; 10(6):453-64.
Score: 0.050
-
Antibodies with specificities to preselected protein regions evoked by free synthetic peptides representing protein antigenic sites or other surface locations: demonstration with myoglobin. Mol Immunol. 1983 May; 20(5):567-70.
Score: 0.048
-
Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG. Autoimmunity. 2002 May; 35(3):183-90.
Score: 0.045
-
Genetic control and intersite influences on the immune response to sperm whale myoglobin. Adv Exp Med Biol. 1982; 150:97-125.
Score: 0.044
-
Genetic control of the immune response to myoglobin. VI. Inter-site influences in T-lymphocyte proliferative response from analysis of cross-reactions of ten myoglobins in terms of substitutions in the antigenic sites and in environmental residues of the sites. Mol Immunol. 1981 Oct; 18(10):945-8.
Score: 0.043
-
Time-dependent study of the antibody response to sperm-whale myoglobin: recognition of the antigenic sites is unaltered over an extended period of immunization. Mol Immunol. 1981 Jun; 18(6):473-9.
Score: 0.042
-
Suppression of experimental myasthenia gravis by monoclonal antibodies against MHC peptide region involved in presentation of a pathogenic T-cell epitope. J Neuroimmunol. 2000 Jun 26; 105(2):131-44.
Score: 0.040
-
Immunochemistry of serum albumin--V. A time-dependent examination of the antibody response to bovine serum albumin by the activity of its third domain. Mol Immunol. 1979 Jul; 16(7):451-6.
Score: 0.037
-
B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor. J Immunol. 1996 Oct 01; 157(7):3192-9.
Score: 0.031
-
Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide. Proc Natl Acad Sci U S A. 1992 Jul 01; 89(13):5852-6.
Score: 0.023
-
Perspectives of the immunology of proteins. Adv Exp Med Biol. 1985; 185:1-25.
Score: 0.014
-
Production of monoclonal antibodies to surface regions that are non-immunogenic in a protein using free synthetic peptide as immunogens: demonstration with sperm-whale myoglobin. Immunol Commun. 1983; 12(2):161-75.
Score: 0.012
-
Antibodies with preselected specificities to protein regions evoked by immunization with free synthetic peptides: dose response to myoglobin antigenic sites reveal an optimum dose for each antigenic site. Immunol Commun. 1983; 12(4):419-28.
Score: 0.012
-
Genetic control of the immune response to myoglobin. IX. Overcoming genetic control of antibody response to antigenic sites by increasing the dose of antigen used in immunization. J Immunogenet. 1982 Oct; 9(5):343-51.
Score: 0.012
-
Antibodies to sperm-whale myoglobin evoked by free synthetic peptides of an antigenic site. Immunol Commun. 1982; 11(1):9-16.
Score: 0.011
-
Genetic control of the immune response to haemoglobin. III. Variant A beta (bm12) but not Ae (D2.GD) Ia polypeptides alter immune responsiveness towards the alpha -subunit of human haemoglobin. J Immunogenet. 1981 Dec; 8(6):471-6.
Score: 0.011
-
Genetic control of the immune response to myoglobin. VII. Antibody responses to myoglobin variants reveal that gene restriction of the antibody responses to myoglobin antigenic sites is dependent on the chemical properties of the sites. Immunol Commun. 1981; 10(6):483-98.
Score: 0.010
-
Genetic control of the immune response to hen's egg-white lysozyme in mice. I. Antibody and T-lymphocyte proliferative responses to the native protein. J Immunogenet. 1979 Dec; 6(6):447-52.
Score: 0.010
-
Evidence for cellular but not serologic cross-reactivity between keyhole limpet hemocyanin and sperm-whale myoglobin. Cell Immunol. 1979 Sep 01; 46(2):384-97.
Score: 0.009
-
Synthetic myoglobin peptides inhibit spontaneous anamnestic antibody responses by myoglobin-primed rabbit lymph node cells. Cell Immunol. 1979 Jun; 45(1):195-8.
Score: 0.009
-
Immunochemistry of serum albumin. VI. A dynamic approach to the immunochemical cross reactions of proteins using serum albumins from various species as models. Biochim Biophys Acta. 1979 Feb 26; 576(2):322-32.
Score: 0.009
-
Precise determination of the entire antigenic structure of lysozyme: molecular features of protein antigenic structures and potential of "surface-simulation" synthesis--a powerful new concept for protein binding sites. Immunochemistry. 1978 Dec; 15(12):909-36.
Score: 0.009
-
In vitro responses of myoglobin-primed lymph node cells to myoglobin and myoglobin synthetic antigenic peptides. Adv Exp Med Biol. 1978; 98:199-219.
Score: 0.008
-
Production of autoantibodies by immunization with rabbit myglobin. Immunochemistry. 1978 Jan; 15(1):67-70.
Score: 0.008
-
Immunochemistry of serum albumin--IV. Immunochemical cross-reaction of fragments from the first third and the last third of bovine serum albumin. Immunochemistry. 1977 Jun; 14(6):449-57.
Score: 0.008
-
In vitro responses of primed rabbit lymph node cells to myoglobin and its synthetic antigenic peptides: production of macrophage inhibitory factor and antibody to myoglobin. Immunochemistry. 1975 Dec; 12(12):959-65.
Score: 0.007
-
Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor. Clin Immunol Immunopathol. 1993 Mar; 66(3):230-8.
Score: 0.006
-
Myoglobin-reactive T cell clones. Adv Exp Med Biol. 1982; 150:159-82.
Score: 0.003
-
Genetic control of the immune response to haemoglobin. II. Studies using purified alpha-chain and beta-chain as immunogens. J Immunogenet. 1981 Oct; 8(5):395-403.
Score: 0.003